
Jiang Chang
Present position:Associate Professor
Address: School of Public Health Tongji Medical College Huazhong University of Science & Technology Wuhan 430030, China
Telephone: Tel: 86-27-83650744 (lab)
Email: changjiang815@gmail.com
Education
09/2009-07/2014 Doctoral Degree of Philosophy
State Key Laboratory of Molecular Oncology,
Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union MedicalCollege,Beijing, China
Advisor: Dr. Dongxin Lin
09/2005-07/2009 Bachelor’s Degree of Biological Science
College of Life Science
Nankai University, Tianjin, China
Languages
Chinese, English
Work experience
07/2014-11/2017 Assistant Professor
School of Public Health
Tongji Medical College
Huazhong University of Science & Technology
11/2017-present Associate Professor
School of Public Health
Tongji Medical College
Huazhong University of Science & Technology
Present Active Research Programs
1. Functional analysis based fine-mapping of GWAS identified colorectal susceptible loci 10q22.3. Supported by NSFC, From 2016/01-2018/12 (180,000 RMB). (PI).
2. Study of association between genetic variants affecting protein phosphorylation level and susceptibility to esophageal squamous cell carcinoma. Supported by NSFC, From 2019/01-2022/12 (580,000 RMB). (PI).
Publications
1. Chang J#, Zhong R#, Tian J#, Li J#, et al. Exome-wide analyses identify low-frequency variant in CYP26B1 and additional coding variants associated with esophageal squamous cell carcinoma. Nat Genet 50, 338-343 (2018).
2. Chang J#, Tian J#, Zhu Y#, Zhong R#, et al. Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations. Nat Commun 9, 3688 (2018)
3. Yang Y, et al, Chang J*, Miao X*. AWESOME: A database of SNPs that affect protein post-translational modifications. Nucleic Acids Research (2018). (*Corresponding author)
4. Chang J#, Tian J#, Yang Y#, Zhong R#, et al. A rare missense variant in TCF7L2 associates with colorectal cancer risk by interacting with a GWAS-identified regulatory variant in the MYC enhancer. Cancer Res 78(17), 5164-5172 (2018).
5. Chang J#, Tan W#, Ling Z#, Xi R#, Shao M#, Chen M#, et al. Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations. Nat Commun 8, 15290 (2017).
6. Li J, Wang Y, et al, Zhong R* & Chang J*. Breast cancer risk-associated variants at 6q25.1 influence risk of hepatocellular carcinoma in a Chinese population. Carcinogenesis 38, 447-454 (2017). (*Corresponding author)
7. Chang J#, Wei L#, et al. Two novel variants on 13q22.1 are associated with risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 24, 1774-80 (2015).
8. Chang J, et al. Risk prediction of esophageal squamous-cell carcinoma with common genetic variants and lifestyle factors in Chinese population. Carcinogenesis 34, 1782-6 (2013).
9. Tan D E#, Foo J N#, Bei J X#, Chang J#, et al. Genome-wide association study of B cell non-Hodgkin lymphoma identifies 3q27 as a susceptibility locus in the Chinese population. Nat Genet 45, 804-7 (2013).
10. Wu C#, Kraft P#, Zhai K#, Chang J#, et al. Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat Genet 44, 1090-7 (2012).